DSM showcases 24 hours of its ingredients at in-cosmetics

The display, covering a day in the life of the skin, aims to show that the two companies combined can provide solutions for neds of the skin throughout the day.

Asked why the company had waited so long to present the combined portfolio, DSM's director of personal care Michael Weller said it took time to understand each company's strengths and such a combined approach would not have been possible earlier.

Pentapharm brand will not be lost​

Although the combined portfolio reflects the integration of Pentapharm into the company, Weller was adament that the identity of the Swiss brand shall not be lost.

'DSM is the umbrella brand, Pentapharm is the innovative skin care brand,'​ he explained.

The identity of the brand is well known within the industry as a skincare specialist and it would not be in the interest of the company to lose that, he said.

Looking to the future, Weller explained that Pentapham will provide much of the research and development in the cosmetics portfolio, and DSM the worldwide marketing managemant.

The newest ingredients release, Regu-Cea, which is designed to act against the symptoms of rosecea, was already in development by Pentapharm when DSM acquired it in 2007.

'It was cooling in the Pentapharm pipeline and now DSM has adapted it for broad use,'​ said Weller.

Adapted Pentapharm offerings will contribute to future releases as well as new ingredients from the joint business development team, he said.

Modify Pentapharm portfolio​

'Pentapharm's portfolio holds a lot of potential and we hope to adapt them by modifying the technical specifications and providing new data on the ingredients,' ​he said.

In addition, the director of personal care underlined the importance of Pentapharm's knoweldge about the skin.

It is thanks to this knoweldge that the company was able to present the combined portfolio in the 24 hour manner and new concepts may also be launched in the future, along with new ingredients.